Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Guides On Adding Biosimilar Indications
Agency Proposes Streamlined Pathway For Biosimilar Indication Carve-Ins
Feb 10 2020
•
By
Sue Sutter
Biosimilar sponsors in the US can get supplements for new indications teed up and ready for approval upon expiry of an innovator’s exclusivity or patent protection • Source: Shutterstock
More from Biosimilars
More from Products